Treatments for people who use anabolic androgenic steroids: a scoping review

Bates, G., Van Hout, M.-C., Tay Wee Teck, J. and McVeigh, J. (2019) Treatments for people who use anabolic androgenic steroids: a scoping review. Harm Reduction Journal, 16(1), 75. (doi: 10.1186/s12954-019-0343-1) (PMID:31888665) (PMCID:PMC6937954)

[img]
Preview
Text
207512.pdf - Published Version
Available under License Creative Commons Attribution.

781kB

Abstract

Background: A growing body of evidence suggests that anabolic androgenic steroids (AAS) are used globally by a diverse population with varying motivations. Evidence has increased greatly in recent years to support understanding of this form of substance use and the associated health harms, but there remains little evidence regarding interventions to support cessation and treat the consequences of use. In this scoping review, we identify and describe what is known about interventions that aim to support and achieve cessation of AAS, and treat and prevent associated health problems. Methods: A comprehensive search strategy was developed in four bibliographic databases, supported by an iterative citation searching process to identify eligible studies. Studies of any psychological or medical treatment interventions delivered in response to non-prescribed use of AAS or an associated harm in any setting were eligible. Results: In total, 109 eligible studies were identified, which included case reports representing a diverse range of disciplines and sources. Studies predominantly focussed on treatments for harms associated with AAS use, with scant evidence on interventions to support cessation of AAS use or responding to dependence. The types of conditions requiring treatment included psychiatric, neuroendocrine, hepatic, kidney, cardiovascular, musculoskeletal and infectious. There was limited evidence of engagement with users or delivery of psychosocial interventions as part of treatment for any condition, and of harm reduction interventions initiated alongside, or following, treatment. Findings were limited throughout by the case report study designs and limited information was provided. Conclusion: This scoping review indicates that while a range of case reports describe treatments provided to AAS users, there is scarce evidence on treating dependence, managing withdrawal, or initiating behaviour change in users in any settings. Evidence is urgently required to support the development of effective services for users and of evidence-based guidance and interventions to respond to users in a range of healthcare settings. More consistent reporting in articles of whether engagement or assessment relating to AAS was initiated, and publication within broader health- or drug-related journals, will support development of the evidence base.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Tay Wee Teck, Joe
Authors: Bates, G., Van Hout, M.-C., Tay Wee Teck, J., and McVeigh, J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > MRC/CSO SPHSU
Journal Name:Harm Reduction Journal
Publisher:BMC
ISSN:1477-7517
ISSN (Online):1477-7517
Published Online:30 December 2019
Copyright Holders:Copyright © The Authors 2019
First Published:First published in Harm Reduction Journal 16(1):75
Publisher Policy:Reproduced under a Creative Commons license

University Staff: Request a correction | Enlighten Editors: Update this record